🇺🇸 FDA

Intelligence Platform

Patents

Browse 1,315 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9957281

Benzodiazepine derivatives as RSV inhibitors

Enanta Pharmaceuticals, Inc. · Granted Tue May 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9949962

Pharmaceutical composition comprising glutarimide derivatives and use thereof in the treat

OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Tue Apr 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9950076

Maytansinoid derivatives, conjugates thereof, and methods of use

REGENERON PHARMACEUTICALS, INC. · Granted Tue Apr 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9937155

Methods of use for trisubstituted benzotriazole derivatives as dihydroorotate oxygenase in

Aurigene Discovery Technologies Limited · Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9925158

Enterically coated cysteamine, cystamine and derivatives thereof

The Regents of the University of California · Granted Tue Mar 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9925157

Enterically coated cysteamine, cystamine and derivatives thereof

The Regents of the University of California · Granted Tue Mar 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9925156

Enterically coated cysteamine, cystamine and derivatives thereof

The Regents of the University of California · Granted Tue Mar 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9902712

Nitrogenous heterocyclic derivatives and their application in drugs

SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Feb 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9890176

Mannose derivatives for treating bacterial infections

Vertex Pharmaceuticals Incorporated · Granted Tue Feb 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9868706

Processes for the preparation of uracil derivatives

Neurocrine Biosciences, Inc. · Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9868725

Isoindoline-1-one derivatives as cholinergic muscarinic M1 receptor positive alloesteric m

Takeda Pharmaceutical Company Limited · Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9856273

ETP derivatives

The Regents of the University of California · Granted Tue Jan 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9856264

Isoquinolinesulfonyl derivative as RHO kinase inhibitor

Medshine Discovery Inc. · Granted Tue Jan 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9855278

Modified release preparations containing oxcarbazepine and derivatives thereof

Supernus Pharmaceuticals, Inc. · Granted Tue Jan 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9849100

Pharmaceutical compositions suitable for parenteral administration comprising aqueous susp

KalVista Pharmaceuticals Limited · Granted Tue Dec 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9849133

Pharmaceutical formulations of xanthine or xanthine derivatives, and their use

Eton Pharmaceuticals, Inc. · Granted Tue Dec 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9840482

Sulfonamide derivatives and pharmaceutical applications thereof

SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Dec 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9834513

Benzylamine derivatives

KalVista Pharmaceuticals Limited · Granted Tue Dec 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9828373

2-amino-pyrido[2,3-D]pyrimidin-7(8H)-one derivatives as CDK inhibitors and uses thereof

SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Nov 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9827255

Fumagillol derivatives

Takeda Pharmaceutical Company Limited · Granted Tue Nov 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9828465

N-maleimidyl polymer derivatives

Nektar Therapeutics · Granted Tue Nov 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9822117

Pyridoindolobenz[b,d]azepine derivatives and uses thereof

DAYA DRUG DISCOVERIES, INC. · Granted Tue Nov 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9815825

Coumarin derivatives and methods of use in treating cystic fibrosis, chronic obstructive p

DISCOVERYBIOMED, INC. · Granted Tue Nov 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9815814

Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods

OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Tue Nov 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted